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An Improved Method for the Synthesis
of Cellulose Membrane-Bound Peptides with Free
C Termini Is Useful for PDZ Domain Binding Studies
fixation to the cellulose support. In principle, free C ter-
mini can be obtained after standard SPOT synthesis
by reversing the peptide orientation (inverted peptides).
Methods for synthesizing free C-terminal resin-bound
[9–11] and cellulose-bound [12] peptides have been
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2Institut fu¨r Klinische Pharmakologie und ties of the inverted peptides are generally low, that gen-
eration of the inverted peptide arrays is extremely timeToxikologie
Garystr. 5 consuming, and that screening the arrays for PDZ inter-
actions is often unsuccessful. We therefore initiated this14195 Berlin
Germany work with the goal of developing a more robust and
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Gloriastr. 30 brane-bound inverted peptide arrays that could be used
for extensive experimental projects mapping different8028 Zu¨rich
Switzerland PDZ domain interactions.
PDZ domains (named after the proteins Post-synaptic
density-95, Discs large, and Zonula occludens 1) [13–15]
are globular protein interaction modules known to bindSummary
C termini of membrane-integrated receptors or channels
[14, 16]. These domains are conserved protein se-SPOT synthesis permits parallel synthesis and screen-
quences of approximately 90 amino acids and play aing of thousands of cellulose membrane-bound pep-
central role in organizing signal transduction complexes,tides to study protein-protein interactions in a proteo-
especially in submembranous compartments. Based onmic context. Recognition of C-terminal residues is one
their target sequence, specific PDZ domains have beenof the most common binding features of PDZ domains.
classified in class I and class II, recognizing peptidesUnfortunately, most solid support-bound peptide li-
with the consensus x(S/T)xφCOOH and xφxφCOOH, respec-braries lack a free C terminus due to C-terminal fixa-
tively [17] (peptide motifs and consensus sequencestion on the solid support. To overcome this restriction,
below are given according to the modified Seefeld Con-we developed a robust methodology based on our
vention 2001 nomenclature [18]). The residues at posi-previous strategy for generating peptides with authen-
tions 0 to 3 of the peptide (position 0 referring to thetic C termini. To validate this improved method, we
C-terminal residue) play a critical role in the specificityscreened a human peptide library of 6223 C termini
and affinity of the PDZ:ligand interaction.with the syntrophin PDZ domain. Furthermore, using
To demonstrate the applicability of the improvedthe same library, new peptide ligands derived from
method, we used the -1-syntrophin (SYNA1) and themembrane proteins and receptors were found for the
ERB2 interacting protein (ERBIN) PDZ domains as mod-ERBIN PDZ domain. Finally, we identified the protein
els. SYNA1 is a cytoplasmic, peripheral membrane pro-kinase breakpoint cluster region, which is known as
tein and a component of the dystrophin-associated pro-a negative regulator of cell proliferation and oncogenic
tein complex (DAPC) [19, 20]. The PDZ domain of SYNA1transformation, as an ERBIN ligand.
recognizes the C termini of various proteins, including
muscle sodium channel protein type IV  subunit [21]
Introduction and the guanylate cyclase soluble, -2 chain [12]. ERBIN
was originally identified as a protein interacting with the
SPOT synthesis [1] (reviewed in [2–4]) opens up opportu- receptor protein tyrosine kinase ERB2 involved in cell
nities to both synthesize and screen large arrays of syn- proliferation and differentiation [22, 23]. In addition,
thetic peptides on planar cellulose supports. This is the ERBIN is known to bind -catenin, the armadillo repeat
remarkable advantage of the SPOT concept, since com- protein deleted in velo-cardio-facial syndrome (ARVCF),
pounds can be rapidly generated and subsequently and p0071 in a PDZ-specific manner [24–26].
screened in parallel, directly on the solid support. In Here, we describe an improved protocol for preparing
recent years, peptide arrays prepared by the SPOT tech- inverted peptide arrays using the SPOT synthesis con-
nique have become popular tools for studying protein- cept and demonstrate its applicability for PDZ binding
protein interactions [5]. assays. The improved protocol allows the rapid and
Some protein domains, such as PDZ domains (re- robust synthesis of large peptide arrays with free C ter-
viewed in [6, 7]), require a free carboxyl terminus (C mini. Short reaction times, together with high coupling
terminus) for ligand recognition. Unfortunately, peptides efficiencies at each step during SPOT synthesis, fewer
synthesized according to the standard SPOT synthesis side reactions, and the possibility of automating the
protocol [8] lack free C termini due to their C-terminal SPOT synthesis process are the considerable advan-
tages of our methodology. Based on Hoffmu¨ller et al.
[12], we screened a similar peptide library with the*Correspondence: rve@charite.de
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Figure 1. Reaction Scheme for the Synthesis
of Inverted Peptides on Cellulose Membranes
Reaction conditions were as follows: a,
Fmoc--alanine-Opfp in DMSO, then piperi-
dine followed by Fmoc-cysteine-(Trt)-Opfp in
NMP and again followed by piperidine for
Fmoc cleavage; b, Mmt-S-CH2-CH2-COOH in
DMF preactivated with HATU and NMI and,
subsequently, dichloroacetic acid, TFA,
TIBS, DCM; c, aqueous solution of Cs2CO3,
then a Fmoc-amino acid 3-bromopropyl ester
(2) in DMF and piperidine; d, peptide synthe-
sis using the standard SPOT synthesis proto-
col [8]; e, Fmoc--alanine-Opfp in NMP, then
piperidine and 2,4-dinitrophenyl-bromoace-
tate in NMP; f, TFA, TIBS, DCM, and, subse-
quently, aqueous solution of Cs2CO3; g, satu-
rated aqueous solution of Li2CO3.
SYNA1 PDZ domain, which enabled us to validate our cellulose membrane carrying a stable N-functionalized
anchor (N-modified cellulose-amino-hydroxypropyl ethermethod. Encouraged by the coincident results, we used
a new synthesized library containing the same peptide membrane [N-CAPE]) [27, 28], which retained the in-
verted peptides (8) (the numbers 1-8 in bold refer tosequences and found new peptide ligands for the ERBIN
PDZ domain, i.e., the calcium-transporting ATPase Figure 1). The inverted and N terminally fixed peptides
(8) display a free C terminus resulting from reversal ofplasma membrane, isoform 1 (ATB1), and the voltage-
gated potassium channel proteins Kv1.4 (CIK4) and the peptide orientation and achieved by successive thi-
oether-cyclization/ester cleavage (Figure 1, f–g). KeyKv1.5 (CIK5). Furthermore, we identified a PDZ-specific
interaction between the breakpoint cluster region (BCR) compounds in the synthesis are the Fmoc-amino acid
3-brompropyl esters (Fmoc-aa-OPBr) (2), the mem-protein kinase and ERBIN, which was validated by co-
precipitation of endogenous ERBIN and BCR. brane-bound mercaptopropionyl cysteine adduct (3),
the matrix-bound amino acid ester derivative (4), and
the cyclic peptide (7). Critical reaction steps are theResults and Discussion
formation of both the cleavable ester bond and the cyclic
peptide (Figure 1, c and f, respectively).SPOT Synthesis of Cellulose Membrane-Bound
Inverted Peptides The decisive step during the synthesis of the key com-
pound (3) is the selective removal of the 4-methoxytri-The reaction scheme for SPOT synthesis of cellulose
membrane-bound inverted peptides is shown in Figure phenyl (Mmt) protection group (Figure 1, b). The acidic
mixture used in the Mmt-deprotection step has to be1. In contrast to the standard SPOT synthesis protocol
[8], synthesis of inverted peptides was performed on a adjusted carefully in order to prevent cleavage of the
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Table 1. Selective Cleavage of S-Mmt Group
Protecting
Groupb
Acidic Conditionsa Mmt Trt
0.5% TFA in DCM  
0.5%–1% TFA in DCM  
1% TFA in DCM   
8% dichloracetic acid in DCM  
8%–15% dichloroacetic acid in DCM  
15% dichloroacetic acid in DCM   
50% acetic acid  
10% dichloroacetic acid, 0.5% TFA in DCMc   
a Mixtures contain additional 5% TIBS; %  v/v.
b, no cleavage; , cleavage;  , immediate and fast cleavage.
Figure 2. Coupling Efficiency of Fmoc-Aino Acid 3-Bromo-Propylc For details, see Experimental Procedures.
Esters (2)
Fmoc-amino acid 3-bromopropyl esters were checked for coupling
to membrane-bound cesium thiolate (3) (Figure 1, c). Fifty-seventriphenylmethyl (Trt) protection group of the cysteine
spots of the cesium thiolate (3) (spot area: 0.25 cm2) on a noncleav-residue. As shown in Table 1, selective removal of the
able membrane were treated with Fmoc-amino acid 3-bromopropylMmt group is achieved by applying a mixture of 10%
esters (2) in DMF. Three spots were used for each bromopropyl
dichloroacetic acid and 0.5% trifluoroacetic acid (TFA) ester derivate (19 bromopropyl esters were tested; cysteine-adduct
followed by the three-times repeated incubation of 10% was omitted). Each spot was treated with 1 	l of the respective
Fmoc-amino acid 3-bromopropyl esters (2) solution (one-letter codedichloroacetic acid, 0.5% trifluoroacetic acid, and 5%
for the amino acids is used). Gray bars indicate a double couplingtriisobutylsilane (TIBS) in dichloromethane (DCM). The
approach using 0.6 M solutions. White bars indicate the use of 0.8 Mkey compound (4) was synthesized by cesium-salt-sup-
solutions and a three times coupling approach. Coupling yields wereported S-alkylation of (3) with a Fmoc-aa-OPBr (2).
determined by measuring the UV absorbance of the released Fmoc
Compounds (2) (except the arginine derivative) were group [28] and are given as the mean loading of one spot (nmol/
prepared in high yields by O-acylation of 1-bromo-3- spot).
propanol with Fmoc-amino acid fluorides [29] using a
“one-pot” reaction (see Supplemental Table S1 and
Supplemental Experimental Procedures in the supple- the cellulose membrane, and we observed no significant
decrease in coupling efficiency even when the S-alkyl-mental data available with this article online). The reac-
tion is characterized by its lack of side reactions. Only ation reaction starts up to 3 hr later. This result is particu-
larly important, since one coupling step with the SPOTthe corresponding Fmoc-amino acids were observed as
impurities in the range of 10%–25%. Racemic products robot-supported preparation of large peptide arrays
may require up to 3 hr.could not be detected, which is in good accordance
with the literature [30]. The Fmoc-arginine 1-bromo-3- Before starting preparation of the key compound (7),
the completed peptide (5) was N terminally elongatedpropanol ester was synthesized according to standard
esterification [31] (Table S1). Yields of the prepared with Fmoc--alanine pentafluorophenyl ester (Pfp) and
bromoacetic acid 2,4-dinitrophenyl ester, respectively,Fmoc-aa-OPBr were determined by analyzing the crude
reaction products using reversed-phase high-perfor- and subsequently its side chains were deprotected (Fig-
ure 1, e). Cyclization of the resulting linear peptide (6)mance liquid chromatography (RP-HPLC) and electro-
spray ionization-mass spectrometry (ESI-MS) as shown involving the formation of a thioether bond (Figure 1, f)
was performed by incubating the membrane with a dilutein Table S1. During the reaction between the Fmoc-aa-
OPBr (2) and the membrane-bound mercaptopropionyl aqueous solution of cesium carbonate. The formation
of cyclic peptides based on thioether has been reportedcysteine adduct (3) (Figure 1, c), the C-terminal amino
acid of the peptide and the ester cleavage site, neces- to show high tolerance for various peptide sequences
and to deliver cyclic peptides in high yields and excellentsary to reverse the peptide orientation, were incorpo-
rated simultaneously. Due to problems arising from the purity [32]. Finally, the generation of peptides with re-
verse sequence orientation (8) was achieved by cleavingubiquitous cellulose hydroxyl functions, we chose the
S-alkylation reaction for selective formation of the ester the ester bond of the cyclic compound (7) using a satu-
rated aqueous solution of lithium carbonate (Figure 1,linkage into a growing peptide chain. Coupling efficien-
cies of the Fmoc-aa-OPBr (3) are shown in Figure 2. g) as described [12].
The formation of cellulose membrane-bound invertedLow coupling efficiencies were found for the Fmoc-aa-
OPBr derivatives of histidine, asparagine, glutamine peptides depends on the rate of peptide thioether cycli-
zation. Therefore, we chose the epitope peptide NYKQT(Trt-protected side chains), and arginine (Pbf-protected
side chain), probably due to sterical hindrance from the SVCOOH of the PSD-95 PDZ3 domain [33] to test the effi-
ciency of thioether cyclization. The bromoacylated pep-bulky protection groups. However, increasing concen-
trations of the critical amino acid derivatives up to 0.8 tide (9) (numbers 9–11 in bold refer to Figure 3) was
synthesized on several cleavable spots (cleavability isM in dimethylformamide (DMF) and repeated coupling
(3
) significantly increased the coupling efficiency (Fig- conferred by incorporating the Fmoc-Rink linker). Three
conditions were used for cyclization: one array was incu-ure 2). Furthermore, the thiolate formation of compound
(3) using 10% cesium carbonate is stable after drying bated with DMF (Figure 3, h-1), the second was first
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treated with a dilute aqueous solution of cesium carbon- BLU; standard deviation  1 
 103 BLU; PDZ domain
binder  5 
 103 BLU; 6223-Humlib: background  9 
ate and then incubated with DMF (Figure 3, h-2), and
the third array was incubated with a solution of cesium 103 BLU; standard deviation 1
 103 BLU; PDZ domain
binder 11
 103 BLU) (A.A. Weiser and R.V.-E., unpub-carbonate (1 mM) in DMF (Figure 3, h-3). After 3 hr, the
peptide products h-1, h-2, and h-3 were cleaved from lished data). Taken together, we obtained signal intensi-
ties for peptide sequences that bind to the SYNA1 PDZthe spots using TFA and analyzed by HPLC and ESI-
MS (Figure 3B). Analysis of the reaction products clearly domain with values ranging between 5 
 103–28 
 103
BLU for the 3514-Humlib and between 11 
 103–519 
demonstrated the efficiency of the thioether-cyclization
reaction using condition h-3. To determine the influence 103 BLU for the 6223-Humlib. The first 30 spots of each
library with the highest intensities were chosen for fur-of the peptide sequence on the cyclization/cleavage
step, we synthesized two further membrane-bound brom- ther investigation: 3514-Humlib with values ranging be-
tween 12
 103–28
 103 BLU and 6223-Humlib betweenacylated peptides: EFHAALGSYVCOOH and QHIDSQK
KACOOH. Cyclization using a dilute aqueous solution of 237 
 103–519 
 103 BLU (Table S2). We observed that
the new method produced a 20-fold increase in signalcesium carbonate (5%, 12 hr) and subsequent analysis
by ESI-MS showed, in both cases, as with h-3, quantita- intensity but only a 3-fold increase in the background
signal. Altogether, we obtained a total of 60 peptidetive and reproducible thioether cyclization (data not
shown). sequences where 3 identical sequences and 17 se-
quences from the 6223-Humlib were not represented inTaken together, only successfully cyclized peptides
will be reversed in their sequence orientation. The uncy- the 3514-Humlib. Of the 40 comparable sequences, all
strong binders from the 3514-Humlib were also foundclized peptides are released during the ester-cleavage
procedure, due to the sensitivity of the ester bound. In as binders in the 6223-Humlib and vice versa. Compared
to the 3514-Humlib, the 6223-Humlib is characterizedaddition, side reactions between neighboring peptide
sequences that perhaps occur during the cyclization by a 2-fold increase in peptide sequence number, by
a 20-fold increase in signal intensity, and by differentstep, e.g., crosslinking via a disulfide bridge or thioether
crosslinking, do not disturb the reversal of peptide orien- incubation/detection procedures. Due to these facts, it
is difficult to directly compare only the 30 strongesttation. Disulfide crosslinked compounds were cleaved
from the membrane, and thioether crosslinked products spots. Comparing all sequences defined as SYNA1 PDZ
binders, we obtain a good correlation between bothalso resulted in inverted peptides.
libraries. The only exception was the rhombotin-1 pep-
tide, which was detected as a strong binder (261 
 103Evaluation of the Novel Strategy
To assess the novel method for synthesizing cellulose BLU) in the 6223-Humlib but showed no signal in the
3514-Humlib. This may by an artifact of large-scalemembrane bound, inverted peptides, we screened a
library of 6223 C termini (11-mers) of human proteins screening that would have to be excluded by additional
experiments, such as substitutional analysis or Biacore(SWISS-PROT database, release 40). This library (Figure
S1) was incubated with SYNA1 PDZ domain (Q61234), measurements.
In accordance with previously published results, weand the results were compared with previously pub-
lished data (incubation of 3514 C termini [7-mers] of detected strong signals for the peptide derivates from
the guanylate cyclase soluble -2 chain (3514-Humlib:human proteins [SWISS-PROT database, release 34]
with SYNA1 PDZ domain) [12]. Due to the greater num- 28 
 103 BLU; 6223-Humlib: 359 
 103 BLU) [12], for
muscle sodium channel protein type IV  subunit (3514-bers of peptide sequences, it is essential that the new
method is less time consuming and more adapted for Humlib: 16
 103 BLU; 6223-Humlib: 197
 103 BLU) [21],
for the stress-activated protein kinase-3 (3514-Humlib:automatic SPOT synthesis. To compare both binding
experiments accurately, we determined the signal inten- sequence not represented; 6223-Humlib: 186
103 BLU)
[34], for glutaminase-L (3514-Humlib: sequence not rep-sity of each spot of the library of 3514 C termini (7-mers)
of human proteins (called 3514-Humlib) and the library resented; 6223-Humlib: 485 
 103 BLU) [35], and a
weaker signal for aquaporin-4 (3514-Humlib: 7 
 103of 6223 C termini (11-mers) of human proteins (called
6223-Humlib) using Boehringer Light Units (BLU). To BLU; 6223-Humlib: 72 
 103 BLU) [36]. This confirms
that the new method enables us to screen the bindingdeduce the peptide sequences that could be counted
as PDZ domain binders, we determine the signal inten- specificities of PDZ domains in a proteomic context.
sity of the background using 20 spots randomly located
on the cellulose membrane. Peptide sequences showing Analysis of the ERBIN PDZ Domain
Binding Specificitya signal intensity higher than the background intensity
plus the double standard deviation were defined as PDZ The new synthesized 6223 C termini library of human
proteins was incubated with the ERBIN PDZ domaindomain binders (3514-Humlib: background  3 
 103
Figure 3. Synthesis and Analysis of the Peptides (10 and 11)
(A) The cyclic peptide (10) was generated according to Figure 1 with -alanine replaced by the Fmoc-Rink linker (for details, see Experimental
Procedures). Conditions used for cyclization were as follows: h-1, DMF, 3 hr; h-2, cesium thiolate, DMF, 3 hr; h-3, cesium carbonate in DMF
(1 mM), 3 hr; i, TFA, water, TIBS, DCM, 3 hr.
(B) ESI mass spectrometry (left) and RP-HPLC (right) of the crude products resulting from the conditions h-1, h-2, and h-3 used in cyclization
of the membrane-bound peptide (9). HPLC and MS analysis of the crude reaction product h-3 indicates that cyclization is quantitative using
this condition. Conditions h-1 and h-2 led to incomplete cyclization of (9). Depending on the conditions used, various amounts of the linear
peptide (11) were detected by HPLC and MS analysis.
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[Q9NR18] (Figure 4A). The PDZ binders were determined
analog to the SYNA1 incubation of the 6223-Humlib by
measuring the background intensity with 20 randomly
located spots on the cellulose membrane (background,
4 
 104 BLU; standard deviation, 1 
 104 BLU; PDZ
domain binder  6 
 104 BLU; signal range, 6 

104–676 
 104 BLU). The sequences of the 40 strongest
interacting peptides are given in Table 2 (310 

104–676 
 104 BLU). The list reveals many membrane
proteins and receptors including the well-known ERBIN
PDZ domain interaction with ARVCF (O00192, spot no.
407) [26]. Surprisingly, we found an interaction with the
muscle sodium channel protein type IV  subunit
(P35499, spot no. 1027) and with the guanylate cyclase
soluble -2 chain (P33402, spot no. 1351), which are
both described as SYNA1 PDZ domain ligands [12, 21].
For further investigations, we selected the voltage-gated
potassium channel protein Kv1.4 (CIK4 [P22459] peptide
CSNAKAVETDVCOOH [Figure 4B]), the voltage-gated po-
tassium channel protein Kv1.5 (CIK5 [P22460] peptide
LCLDTSRETDLCOOH [Figure 4C]), the plasma membrane
Ca(2) ATPases, isoform 1 (ATB1 [P20020] peptide
GSPIHSLETSLCOOH [Figure 4D]), and the breakpoint clus-
ter region protein (BCR [P11274] peptide KRQSILFS-
TEVCOOH [Figure 5A]). Substitutional analysis, in which
each residue of the ligand is substituted by all gene-
encoded L-amino acids (cysteine omitted), enabled us
to identify the key residues of the ligand. The observed
substitutional patterns for these chosen peptides were
generally very similar to each other and typical for the
canonical PDZ:peptide interaction. In all cases, the ER-
BIN PDZ domain shows a clear preference for valine in
ligand position 0, but also tolerates leucine or isoleucine.
Position 1 shows less restriction, but some amino
acids, such as glycine, isoleucine, and valine, are not
tolerated. For position 2, the ERBIN PDZ domain pre-
fers threonine and serine, classifying this PDZ domain
as a class I PDZ domain. Nevertheless, ligands such
as the receptor protein tyrosine kinase ERB2 (peptide
NPEYLGLDVPVCOOH), with a hydrophobic amino acid at
position 2 (class II), can also interact with this PDZ
domain [22]. In position 3, ERBIN prefers a negatively
charged amino acid such as glutamate or aspartate, but
also tolerates substitutions with small or hydrophobic
amino acids. The substitutional analysis showed less
selectivity for ligand positions beyond residue3 (posi-
tions4 to10). Normally, residues N terminal to ligand
position 3 do not contribute substantially to affinity or
specificity of the PDZ domain, although several studies
have shown their participation in PDZ domain-ligand
interactions [37–39].
In addition, dissociation constant (Kd) values for se-
lected peptides (spot nos. 407, 438, 439, 542, 1018,
1027, 1300, and 1351) derived from the 40 strongest
Figure 4. Inverted Peptide Arrays on Cellulose Membranes for Pro- ERBIN PDZ domain-interacting ligands were deter-
tein Binding
(A) Extract from the library of 6223 C termini (11-mers) of human
proteins from the SWISS-PROT database incubated with GST-
labeled ERBIN PDZ domain (cysteine replaced by serine). The 30 (ATB1) (D) incubated with GST-ERBIN-PDZ. Each residue of the
strongest binders are listed in Table 2. peptide ligand was substituted by 19 gene-encoded L-amino acids
(B–D) Substitutional analyses of the peptide derivates from the volt- (cysteine omitted). All spots in the left column are identical and
age-gated potassium channel protein Kv1.4 (CIK4), (B), from the represent the wild-type peptide (wt). All other spots are single substi-
voltage-gated potassium channel protein Kv1.5 (CIK5) (C) and from tution analogs, with rows defining the substituted sequence position
the calcium-transporting ATPase plasma membrane, isoform 1 and columns defining the amino acid used as a replacement.
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Table 2. ERBIN PDZ Binding Peptides from Human Carboxyl Termini
Spot Sequence Accession No. Kd [	M] Protein Description
102 FSTALYGESDL P12814 alpha-actinin 1, cytoskeletal isoform
103 FSSALYGESDL P35609 alpha-actinin 2, skeletal muscle isoform
116 LQDEKVKESYV O95477 ATP-binding cassette, sub-family A, member 1
131 KRNTLYFSTDV Q12979 active breakpoint cluster region-related protein
220 SSLREMETFVS P50052 type-2 angiotensin II receptor (AT2)
336 RHSGSYLVTSV P25054 adenomatous polyposis coli protein (APC protein)
407 DAKPQPVDSWV O00192 8.0  3.1 armadillo repeat protein deleted in velo-cardio-facial
syndrome [26]
438 GSPLHSLETSL P20020 24.5  5.0 plasma membrane calcium-transporting ATPase, isoform 1
439 GSPIHSLETSL Q01814 54.2  4.8 plasma membrane calcium-transporting ATPase, brain
isoform 2
441 DSSLQSLETSV P23634 plasma membrane calcium-transporting ATPase, isoform 4
489 NVDFPPKESSL P27037 activin receptor type II precursor
490 NVDLPPKESSI Q13705 activin receptor type IIb precursor
505 GCLREWCDAFL O75531 barrier-to-autointegration factor
542 KRQSILFSTEV P11274 36.0  5.2 breakpoint cluster region protein
788 FKLLDQMETPL P08311 cathepsin G precursor
1017 CSNAKAVETDV P22459 voltage-gated potassium channel protein KV1.4
1018 LCLDTSRETDL P22460 79.4  2.8 voltage-gated potassium channel protein KV1.5
1027 TVRPGVKESLV P35499 82.7  1.3 sodium channel protein, skeletal muscle alpha-subunit
1168 KINLSQKETSI P53618 coatomer beta subunit
1253 NSRPHTNETSL P23508 colorectal mutant cancer protein
1284 APQWVPVSWVY O14936 peripheral plasma membrane protein CASK
1300 SNQLAWFDTDL P35222 53.1  0.5 beta-catenin
1351 IGTMFLRETSL P33402 115.5  9.2 guanylate cyclase soluble, alpha-2 chain
1668 SPQWVPVSWVY Q00013 55 kDA erythrocyte membrane protein (p55)
1958 KQASSQSWVPG O43524 forkhead protein O3A
3214 SQKVAVYSTCL P07942 laminin beta-1 chain precursor
3340 TLDSQIQETSI P27816 microtubule-associated protein 4
3388 VKRMRMDAWVT Q02078 myocyte-specific enhancer factor 2A
3454 LGARVSKETPL P53778 mitogen-activated protein kinase 12
3528 EPQWVPVSWVY Q14168 MAGUK p55 subfamily member 2
3529 DTHWVPVSWVR Q13368 maguk p55 subfamily member 3
3547 PSTLTIFETAL O15439 multidrug resistance-associated protein 4
3807 WRRISSLESEV Q14957 glutamate [NMDA] receptor subunit epsilon 3 precursor
3848 LLSDMYKSSDI Q9Y466 orphan nuclear receptor NR2E1
3882 GLIAGEKETHL P48065 sodium- and chloride-dependent betaine transporter
4711 QLNGTFESQVQ P25800 rhombotin-1
5027 DGGRDQQETNL Q92911 sodium/iodide cotransporter
5028 SSTCILQETSL Q9Y289 sodium-dependent multivitamin transporter
5840 QSFLQTETSVI P41587 vasoactive intestinal polypeptide receptor 2 precursor
5956 MNDPAWDETNL Q14155 hypothetical protein KIAA0142
Accession numbers refer to the SWISS PROT database; cysteine replaced by serine.
mined by surface plasmon resonance (Biacore) mea- coprecipitated with BCR (Figure 5C, lanes 4 and 6). Com-
petition of the BCR and the ERBIN antibody with theirsurements (Table 2). We obtained Kd values of 8.0 
3.1 	M for AVRCF and 115  10 	M for CYG4, which respective antigen reduced immunoprecipitation, sup-
porting the specificity of the interaction (Figure 5C, lanesare typical for PDZ domain interactions.
To confirm that the BCR peptide interaction observed 3, 5, and 7).
Our results, namely the in vitro interactions betweenin vitro corresponds to protein interactions between
BCR and ERBIN in mammalian cells, we performed a the ERBIN PDZ domain and the three C-terminal pep-
tides derived from the voltage-gated potassium channelpull-down assay by using the PDZ domain of ERBIN
fused to GST. The GST-ERBIN PDZ and the GST protein proteins Kv1.4 and Kv1.5 and the plasma membrane
Ca(2) ATPases, isoform 1, could be relevant interac-alone as a control were incubated with lysates of
HEK293 cells overexpressing BCRWT and a C-terminal tions with regard to a decisive role of the ERBIN PDZ
domain in a neuronal context [40]. Further in vivo experi-mutant BCRV1271A, both as HA-tagged fusions. As pre-
dicted, BCRWT but not the mutant BCRV1271A bound to the ments will be needed to determine the biological rele-
vance of such protein interactions and the ERBIN PDZERBIN PDZ domain (Figure 5B, lanes 1 and 2), whereas
GST protein alone did not bind (Figure 5B, lanes 3 and domain itself.
ERBIN is the founding member of the leucine-rich4). We extended this study to substantiate the biological
relevance of the interaction between full-length ERBIN repeat (LRR) and PDZ domain (LAP) family, which is
characterized by 16 LRRs at the N terminus and 1–4and BCR as endogenous proteins. To test this, BCR
and ERBIN were analyzed in MKN-7 cells, where both PDZ domains at the C terminus [41]. Besides the PDZ-
specific interactions with ERB2, -catenin, ARVCF, orproteins are well expressed (Figure 5C). Indeed, ERBIN
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p0071 [22, 24–26], ERBIN is know to interact with the
small GTPase Ras and Rho through the LRRs [42, 43].
Our novel interacting partner of ERBIN, BCR, is a multi-
domain protein containing a serine/threonine protein ki-
nase domain, a guanine nucleotide exchange factor
(GEF) function, and a GTPase-activating protein (GAP)
domain. The GEF and GAP domains can modulate the
activity of Rho-type GTPases [44, 45]. We suggest that
ERBIN is a scaffold-like protein that links BCR and Rho-
type GTPases into a single complex.
Significance
The SPOT synthesis concept has been widely used
to prepare peptide arrays for proteomic studies. Our
overall goal is to extend the application range of the
SPOT synthesis concept by creating N terminally fixed
inverted peptide arrays, enabling free C-terminal dis-
play on planar cellulose supports. In the context of
proteomic studies, a reliable and robust technology is
required, and this is satisfied by our enhanced syn-
thetic method. We demonstrate here that new ligands
of PDZ domains can be identified in a proteomic con-
text by our extended SPOT synthesis concept. This
could be applied to nonredundant statistical libraries
or libraries based on database sequences. With the
improved and robust methodology, particulary with
regard to automatic, robot-assisted SPOT synthesis,
we were able to screen a large range of divergent
peptide sequences. In addition, the extended SPOT
synthesis concept can provide better insights into
PDZ:ligand interactions due to the various screening
options such as substitutional analyses, combinatorial
libraries, length analyses, and integration of unnatural
building blocks or other chemical entities.
Our screen of 6223 C termini of human proteins
revealed four new peptide ligands for the ERBIN PDZ
domain. The voltage-gated potassium channel pro-
teins Kv1.4 and Kv1.5 and the plasma membrane
Ca(2) ATPases, isoform 1, could be potential ERBIN
PDZ domain ligands in neuronal context. The biologi-
cal relevance of the ERBIN:breakpoint cluster region
protein interaction was substantiated by pull-down
and coprecipitation studies using full-length and/orFigure 5. BCR Is a Ligand of the ERBIN PDZ Domain
endogenous proteins. Our results strengthen the sug-(A) Substitutional analysis of the C-terminal peptide derived from
the breakpoint cluster region (BCR). gestion that ERBIN acts as a scaffold-like protein, link-
(B) Pull-down (PD): HEK293 cells transfected with plasmids encod- ing BCR and Rho-type GTPases into a single complex
ing HA-BCRWT and HA-BCRV1271A were lysed and incubated with GST- via its PDZ domain and LRRs, respectively.
ERBIN-PDZ bound to GSH-agarose beads. Proteins bound to GST
Taken together, these data suggest that the im-fusion proteins were fractioned by SDS-PAGE and immunoblotted
proved method for generating cellulose membrane-(IB) with anti-HA antibody and anti-GST antibody, respectively. As
bound inverted peptides may be a powerful tool tocontrol for the expression of the BCR proteins, direct lysates of the
293 cells were immunoblotted with anti-HA antibody. screen proteomic databases on a large scale and to
(C) Coprecipitation of endogenous ERBIN and BCR in MKN-7 cells. find new ligands for PDZ domains.
The lysate of MKN-7 cells was incubated with anti-BCR antibody
in the absence (top panel, lanes 4, 6) or presence of BCR peptide
Experimental Procedures
( comp.) (top panel, lanes 5, 7) followed by immunoblotting with
anti-ERBIN. Expression of endogenous ERBIN and BCR was verified
Synthesis of Membrane-Bound Inverted Peptide Arrays
by immunoprecipitation with anti-ERBIN (top panel, lane 2) with anti-
The peptides were synthesized on N-modified CAPE membranes
BCR (bottom panel, lane 2), and by analysis of the direct lysate with
[28] and prepared semiautomatically using a SPOT robot (INTAVIS
anti-ERBIN (top panel, lane 1) and anti-BCR (bottom panel, lane 1).
Bioanalytical Instruments AG, Cologne, Germany). Array design was
performed using the in-house software LISA 1.571. The synthesis
started with the spot definition using a standard protocol [8] followed
by the coupling of a 0.3 M solution of Fmoc-cysteine-(Trt)-Opfp in
N-methyl-pyrolidone (NMP) (double coupling, 15 min each). After
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Fmoc cleavage with 20% piperidin in DMA, Mmt-mercaptopropionic vacuo. Peptide precipitation was achieved by the addition of 100
	l diethyl ether and completed by centrifugation. After separation,acid was dissolved in DMF (1 M solution), activated with 1 equiv.
HATU and 2 equiv. NMI, and directly spotted on the membrane; the pellet was washed five times with diethyl ether and finally dried.
The compounds were dissolved in 50% aqueous acetonitrile (200after 15 min this step was repeated. The membrane was washed
with DMA (3 
 3 min) and DCM (3 
 3 min). The Mmt group was 	l), and purity was checked by analytical HPLC (Waters, Eschborn,
Germany) on a Vydac C 18 column. Cyclic compounds (10) wereremoved using treatments of 10% (v/v) dichloroacetic acid and 0.5%
(v/v) TFA in DCM for 1 
 5 min followed by 10% (v/v) dichloroacetic identified using ESI mass spectrometry.
Cyclic Peptide (10), C50H79N13O17S2acid, 0.5% (v/v) TFA, and 5% (v/v) triisobutylsilane (TIBS) in DCM
for 3 
 5 min. The membrane was washed with DCM (1 
 3 min), ESI-MS: mass calculated (monoisotopic): 1197.5158, mass found:
1197.6578 (found as m/z: 599.7657 [M2H]2); HPLC: retention time:EtOH (2
 3 min), water (2
 3 min), 10% aqueous solution of cesium
carbonate for forming the cesium thiolate (1 
 2 min), water (1 
 12.01 min.
Linear Peptide (11), C50H80BrN13O17S230 s), EtOH (2 
 30 s), diethyl ether (2 
 30 s), and finally air dried.
Solutions of the Fmoc amino acid 3-bromopropyl esters in DMF ESI-MS: mass calculated (monoisotopic): 1277.4437, mass found:
1277.5972 (found as m/z: 639.7986 [M2H]2); HPLC: retention time:were spotted on the membrane (0.6 M solutions; 0.8 M solutions
for C, H, N, Q, and R; triple coupling, 15 min each). The Fmoc group 10.11 min.
was removed from the spots, and the sequences of the peptides
were completed using the standard SPOT synthesis protocol [8] PDZ Preparation
and followed by a N-terminal tag with -alanine. For standard SPOT DNA fragments encoding residues 1280 to 1371 of ERBIN and 81
synthesis, Fmoc-aa-Opfp were used with the following side-chain to 164 of SYNA1 were cloned into pGEX6p2 and pGAT2 expression
protections: E-, N-(OtBu); S-, T-, Y-(tBu); K-, W-(Boc); N-, Q-, H-(Trt); vectors, respectively. E. coli BL21(DE3) cultures harboring the ex-
R-(Pbf). For thioether cyclization, all peptides were N-acylated with pression plasmid were grown at 37C to mid-log phase (OD600 
bromoacetic acid 2,4-dinitrophenyl ester in NMP (1 M), double cou- 0.5). Protein expression was induced by addition of 1.0 mM IPTG,
pling, 15 min each. The membrane was washed with DMA (3 
 3 and cells were harvested 3.5 hr later by centrifugation at 7800 
 g
min), DCM (3 
 3 min), and dried. Side chain protection groups for 10 min at 4C. The pellet was washed and resuspended in 20
were removed using one treatment of 90% TFA and 3% TIBS in mM Tris, Complete (protease inhibitor cocktail tablets, Roche,
DCM for 30 min without shaking, followed by washing steps includ- Mannheim, Germany) (pH 8.0) and stored at 80C.
ing DCM 3 
 3 min, DMA 3 
 3 min, EtOH 3 
 3 min, and diethyl The cells were lysed using a French press (ThermoSpectronic,
ether 2 
 3 min, followed by 50% TFA and 3% TIBS in DCM for 2.5 Rochester, NJ), centrifuged for 30 min at 75,800
 g, and the super-
hr without shaking. The membrane was washed with DCM (3 
 3 natant was loaded onto a SP-Sepharose column (Amersham Bio-
min), DMA (3 
 3 min), EtOH (2 
 3 min), 0.1 M phosphate buffer siences, Freiburg, Germany). The column was washed with PBS (pH
pH 7.4 (2 
 3 min) and water (2 
 3 min). The membrane-bound 7.4), and then the GST-tagged protein was eluted with 50 mM Tris
peptides were cyclized by incubating the membrane with a 5% (pH 8.0), 10 mM reduced glutathione. Fractions containing the pro-
aqueous solution of cesium carbonate for approximately 12 hr. The tein of interest were pooled, concentrated, and used for cellulose
membrane was washed five times with water, and the membrane- incubation.
bound cyclized peptides were inverted by ester-hydrolysis, using
one treatment with a saturated aqueous solution of lithium carbon- Binding Studies of Cellulose-Bound Peptides
ate. Finally, the membrane was washed with water (3 
 3 min), 1% The nonredundant library of 6223 C termini (11-mers) of human
hydrochloric acid (1 
 3 min), water (2 
 3 min), EtOH (2 
 3 min), proteins from the SWISS-PROT database (release 40) and all substi-
diethyl ether (2 
 3 min), and air dried. tution analogs of ligands (“substitutional analysis of ligands”) were
generated by a semiautomated SPOT robot [1, 8] (Abimed, Langen-
feld, Germany; LISA, in-house software) using the novel strategy.SPOT Synthesis and Chemical Characterization
The human C termini library and the substitutional analysis wereof the Peptides (10, 11)
prewashed once with EtOH (1 
 10 min), with Tris-buffered salineSynthesis of peptides was performed by manually pipetting 1 	l of
(TBS) (pH 8.0) (3 
 10 min), then blocked for 4 hr with blockingeach reagent solution onto the spots (spot area: 0.25 cm2). Three
buffer (blocking reagent [Sigma-Genosys, Cambridge, UK] in TBSarrays were generated, each consisting of eight identical spots.
[pH 8.0] containing 5% sucrose). The membranes were incubatedCleavability of the prepared peptides and spot definition were
with PDZ-GST (10 	g/ml) in blocking buffer overnight at 4C andachieved by spot-wise treatment of the N-modified CAPE membrane
washed with TBS (pH 8.0) (3
 10 min), followed by a second incuba-with a TBTU-activated 0.3 M solution of the Fmoc-Rink linker (Cal-
tion with anti-GST-HRP (Amersham Biosiences, Freiburg, Germany)biochem-Novabiochem GmbH, Bad Soden, Germany) in DMF (1
(1 	g/ml) in blocking buffer for 3 hr at room temperature. To removeequiv. Fmoc-Rink linker, 1 equiv. TBTU, and 2 equiv. DIEA). After
excess antibody, the membrane was washed with TBS pH 8.0 (3 
15 min, the procedure was repeated using a freshly prepared reagent
10 min). A chemiluminescence system (Pierce Biotechnology, Rock-solution. Synthesis of the peptides (9) by coupling Fmoc-cysteine-
ford, IL) was applied for detection using a LumiImager (Boehringer(Trt)-Opfp, Mmt-mercaptopropionic acid, and standard SPOT syn-
Mannheim GmbH, Mannheim, Germany). The signal intensities werethesis was performed according to the protocol described above.
recorded as Boehringer light units (BLU) using the LumiAnalystRemoval of the cysteine Trt group was achieved by treatments of
software.2% (v/v) TFA in DCM for 1 
 5 min and 2% (v/v) TFA, 5% (v/v) TIBS
in DCM for 3 
 5 min. The membrane was washed with DCM (3 

3 min), air dried, and the three arrays were separated by cutting the Affinity Measurements
The binding affinity (Kd) was measured using the BIACORE X systemmembrane. For cyclization, each part was treated in a different
manner: h-1, incubation with DMF for 3 hr; h-2, the membrane was (Uppsala, Sweden).
PDZ-GST was immobilized on a CM5 chip using the GST couplingwashed with EtOH (2
 3 min) and water (2
 3 min), then incubated
with a 5% aqueous solution of cesium carbonate for 1 min, washed procedure, according to the supplier’s instructions. The amount of
covalently coupled protein corresponded to a signal increase ofwith water (6 
 1 min), EtOH (1 
 3 min), DMF (2 
 3 min), and
incubated with DMF for 3 hr; and h-3, the membrane was washed approximately 500 resonance units (RU). An appropriate amount
of GST was coupled to flowcell 1 on the same chip as a reference.with DMF (2
 3 min) and incubated with a 1 mM solution of cesium
carbonate in DMF for 3 hr. Subsequently, all membranes were All binding, experiments were performed at 20C with a flow rate
of 5 	l/min (injection volume 10 	l). Peptides were used at variouswashed with DMF (2 
 3 min), DCM (3 
 3 min), and dried. The
spots were punched out from each membrane and transferred to concentrations between 1 	M and 1 mM in HBS buffer (10 mM
HEPES with 0.15 M NaCl, 3.4 mM EDTA, and 0.005% surfactant P20eppendorf tubes. Cleavage from the solid support and amino acid
side chain deprotection were performed simultaneously by adding [pH 7.4]). Complete regeneration was obtained after dissociation
without regeneration buffer. Transformation of data and analysisa solution (300 	l) of 90% TFA, 5% water, and 3% TIBS in DCM to
each tube. The tubes were shaken for 3 hr, the cellulose membranes were performed with the BIA-evaluation software, version 3.0. The
control sensorgram (flowcell 1) was subtracted from the sen-were taken out, and the resultant solution was concentrated in
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sorgrams obtained with flowcell 2. The steady-state values of the tides and peptide libraries: another end to peptide synthesis.
Angew. Chem. Int. Ed. Engl. 36, 1097–1110.binding equilibrium were plotted versus the different peptide con-
centrations and fitted using the implemented steady-state evalua- 10. Davies, M., Bonnat, M., Guiller, F., Kilburn, J.D., and Bradley,
M. (1998). Screening an inverted peptide library in water with ation, resulting in the Kd for the PDZ-peptide complexes.
guanidinium-based tweezer receptor. J. Org. Chem. 63, 8696–
8703.Pull-Down and Coimmunoprecipitation Assays
11. Kania, R.S., Zuckermann, R.N., and Marlove, C.K. (1994). FreeThe full-length BCRWT and the mutant BCRV1271A were described else-
C-terminal resin-bound peptides: reversal of peptide orientationwhere [46]. Pull-down and immunoprecipitation of BCR and HA-
via a cyclization/cleavage protocol. J. Am. Chem. Soc. 116,BCR were performed with rabbit polyclonal anti-BCR C20 (Santa
8835–8836.Cruz Biotechnologie) for BCR and Mab 12CA5 (Roche diagnostics)
12. Hoffmu¨ller, U., Russwurm, M., Kleinjung, F., Ashurst, J., Oschki-for HA-BCR. GST-ERBIN PDZ and ERBIN were analyzed with anti-
nat, H., Volkmer-Engert, R., Koesling, D., and Schneider-GST (Amersham Pharmacia Biotech) for GST-ERBIN and anti-ERBIN
Mergener, J. (1999). Interaktion einer PDZ-Proteindoma¨ne mit(in-house production, Radziwill, Swizerland) for ERBIN, respectively.
einer synthetischen Bibliothek aller C-Termini humaner Pro-Human embryonic kidney 293 (HEK293) and human gastric adeno-
teine. Angew. Chem. 111, 2180–2184.carcinoma (MKN7) cells were cultured at 37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13. Woods, D.F., and Bryant, P.J. (1993). ZO-1, DlgA and PSD-95/becco’s modified Eagle’s medium containing 10% fetal calf serum,
SAP90: homologous proteins in tight, septate and synaptic cell100 U penicillin/ml, and 100 	g of streptomycin/ml. Transfection
junctions. Mech. Dev. 44, 85–89.was performed based on standard calcium-phosphate methods,
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